Article Versions Notes

Urru SAM, Mayer F, Spila Alegiani S, Paoloni F, Guella A, Murru R, Bucaneve G, Formoso G, Racanelli V, Ferrarini I, et al. The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population. Cancers. 2024; 16(19):3419. https://doi.org/10.3390/cancers16193419

Urru, Silvana A. M., Flavia Mayer, Stefania Spila Alegiani, Francesca Paoloni, Anna Guella, Roberta Murru, Giampaolo Bucaneve, Giulio Formoso, Vito Racanelli, Isacco Ferrarini, and et al. 2024. "The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population" Cancers 16, no. 19: 3419. https://doi.org/10.3390/cancers16193419

Urru, S. A. M., Mayer, F., Spila Alegiani, S., Paoloni, F., Guella, A., Murru, R., Bucaneve, G., Formoso, G., Racanelli, V., Ferrarini, I., Fozza, C., Longo, G., Musicco, F., & Campomori, A. (2024). The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population. Cancers, 16(19), 3419. https://doi.org/10.3390/cancers16193419